期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 53, 期 19, 页码 6954-6963出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm100576z
关键词
-
资金
- Saarland University, Germany
- Ministry of Ficonomics and Science or Saarland
- DFG [JA1741/2-1, HE3553/2-1]
- European Community [FP7/2007-2013, 215009]
- Deutsche Krebshilfe Max-Eder
- Cologne University
- Bayer Health Care Preferred Partnership Pharmacology Program
- Recherche Cancer et Sangfoundation
- Recherches Scientiliques Luxembourg
- Een Haerz fir kriibskrank Kanner association
- Action lions ''Vaincre le Cancer Luxembourg
- Televie Luxembourg
Many tumor cells exhibit a disturbed intracellular redox state resulting in higher levels of reactive oxygen species (ROS). As these contribute to tumor initiation and sustenance, catalytic redox agents combining significant atctivity with substrate specificity promise high activity andselectivity L. Must oxidatively stressed malignant cells. We describe here the design and synthesis of novel organochalcogen based redox sensor/effector catalysts. Their selective anticancer activity at submicromolar and low micromolar concentrations was established here in a range of tumor entities in various biological systems including cell lines, primary tumor cell cultures, and animal models. In the B-cell derived chronic lymphocytic leukemia (CLL), for instance, such compounds preferentially induce apoptosis in the cancer cells while peripheral blood mononuclear cells (PBMC) from healthy donors and the subset of normal 13-cells remain largely unaffected. In support of the concept of sensor/effector based ROS amplification, we are able to demonstrate that underlying this selective activity against CI.I. cells are pre-existing, elevated ROS levels in the leukemic cells compared to their nonmalignant counterparts. Furthermore, the catalysts act in concert with certain chemotherapeutic drugs in several carcinoma cell lines to decrease cell proliferation while showing no such interactions in normal cells. Overall, the high efficacy and selectivity of. (redox) catalytic sensor/effector compounds warrant further, extensive testing toward transfer into the clinical arena.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据